OTC · Drug Manufacturers - Specialty & Generic

Curative Biosciences, Inc. (CBDX) Stock

$0.00 OTC: CBDX Healthcare

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol.

Valuation

MetricValue
Price$0.00
Market Cap$25789
P/E Ratio-0.03
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.00%
ROA—
ROCE8.43%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric20162017
Revenue$0$0
Operating Profit$-2.0M$0
Net Profit$-2.0M$0
EPS$-0.12$0.00
Op Margin——

Balance Sheet (USD)

Metric20162017
Total Assets$0$0
Total Liabilities$1.0M$1.0M
Cash$0$0
Borrowings$0$0

Cash Flow (USD)

Metric20162017
Operating Cash Flow$0$0
Investing Cash Flow$0$0
Financing Cash Flow$0$0
Net Cash Flow$0$0
Free Cash Flow$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.76
FCF Yield-49.62%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y0.00%
Return 3Y-92.86%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Vermillion Wealth Management, Inc. 1,0002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACURAcura Pharmaceuticals, Inc. $0.00 — 0.00 $6600 0.00%
AZFLAmazonas Florestal, Ltd $0.00 — — $25088 0.00%
CNNCCannonau Corp. $0.00 — 0.00 $72413 0.00%
FLHLFFilament Health Corp. $0.00 — -1.89 $26179 0.00%
GMVDFG Medical Innovations Holdings Ltd $0.00 — 0.00 $25992 0.00%

About Curative Biosciences, Inc.

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.

Curative Biosciences, Inc. (CBDX) stock trades at $0.00 with a market capitalization of $25789. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Curative Biosciences, Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of 8.43%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.curativebio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides